Rapid pulmonary expression of acute-phase reactants after local lipopolysaccharide exposure in mice is followed by an interleukin-6 mediated systemic acute-phase response

Experimental Lung Research

Volumn 31, Issue 9-10, 2005, Pages 855-871

  Vernooy, Juanita H J ^a,b   Reynaert, Niki ^a   Wolfs, Tim G A M ^a   Cloots, Roy H E ^a   Haegens, Astrid ^a   De Vries, Bart ^a   Dentener, Mieke A ^a   Buurman, Wim A ^a   Wouters, Emiel F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute phase response; Inflammation; Innate immunity; Lipopolysaccharide; Lung

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; BETA ACTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MESSENGER RNA; OROSOMUCOID; SERUM AMYLOID P; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOPATHOLOGY; IN VIVO STUDY; LIVER CELL; LUNG INJURY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ALPHA 1-ANTITRYPSIN; ANIMALS; CARRIER PROTEINS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MICE; OROSOMUCOID; TRACHEA;

EID: 33646672202     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140600611645     Document Type: Article

References (52)

1. Heumann D, Roger T: Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta. 2002;323:59-72.
2. Kline JN, Cowden JD, Hunninghake GW, Schutte BC, Watt JL, Wohlford Lenane CL, Powers LS, Jones MP, Schwartz DA: Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med. 1999;160:297-303.
3. Rylander R, Haglind P, Lundholm M: Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroom. Am Rev Respir Dis. 1985;131:209-213.
4. Del A, Godshali MA, Palmgren MS: Gram-negative bacterial endotoxins in grain elevator dusts. Am Ind Hyg Assoc J. 1984;45:336-339.
5. Michel O, Kips J, Duchateau J, Vertongen F, Robert L, Collet H, Pauwels R, Sergysels R: Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med. 1996;154:1641-1646.
6. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W: Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115:829-835.
7. Clapp WD, Thorne PS, Frees KL, Zhang X, Lux CR, Schwartz DA: The effects of inhalation of grain dust extract and endotoxin on upper and lower airways. Chest. 1993;104:825-830.
8. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA: Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest. 1996;110:263-270.
9. Michel O, Nagy AM, Schroeven M, Duchateau J, Neve J, Fondu P, Sergysels R: Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med. 1997; 156:1157-1164.
10. Michel O, Dentener M, Corazza F, Buurman W, Rylander R: Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol. 2001;107:797-804.
11. Michel O, Duchateau J, Plat G, Cantinieaux B, Hotimsky A, Gerain J, Sergysels R: Blood inflammatory response to inhaled endotoxin in normal subjects. Clin Exp Allergy. 1995;25:73-79.
12. De Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA: A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. J Immunol. 1998;161:3607-3615.
13. Weiss J: Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans. 2003;31:785-790.
14. Fournier T, Medjoubi NN, Porquet D: Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482:157-171.
15. Bucurenci N, Blake DR, Chidwick K, Winyard PG: Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett. 1992;300:21-24.
16. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW: Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993;178:1629-1636.
17. Reid PT, Sallenave JM: Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease. Curr Opin Investig Drugs. 2001;2:59-67.
18. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP: New insights into the biology of the acute phase response. J Clin Immunol. 1999;19:203-214.
19. Dentener MA, Vreugdenhil AC, Hoet PH, Vernooy JH, Nieman FH, Heumann D, Janssen YM, Buurman WA, Wouters EF: Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol. 2000;23:146-153.
20. Crestani B, Rolland C, Lardeux B, Fournier T, Bernuau D, Pous C, Vissuzaine C, Li L, Aubier M: Inducible expression of the alpha1-acid glycoprotein by rat and human type II alveolar epithelial cells. J Immunol. 1998;160:4596-4605.
21. Guadiz G, Sporn LA, Goss RA, Lawrence SO, Marder VJ, Simpson Haidaris PJ: Polarized secretion of fibrinogen by lung epithelial cells. Am J Respir Cell Mol Biol. 1997;17:60-69.
22. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF: Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells. No role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol. 2001;24:569-576.
23. Bopst M, Haas C, Car B, Eugster HP: The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. Eur J Immunol. 1998;28:4130-4137.
24. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311-320.
25. Schumann RR, Zweigner J: A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med. 1999;37:271-274.
26. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA: Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br J Surg. 1993;80:1055-1058.
27. Dentener MA, Smit FT, Francot GJ, Buurman WA: Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein. J Infect Dis. 1994;170:1483-1489.
28. Minnich M, Kueppers F, James H: Alpha-1-antitrypsin from mouse serum isolation and characterization. Comp Biochem Physiol B. 1984;78:413-419.
29. Le Roy D, Glauser MP, Heumann D: LPS binding protein (LBP) function in germfree mice. J Endotox Res. 1997;4:183-187.
30. Daemen MA, Heemskerk VH, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P, Buurman WA: Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation. 2000;102:1420-1426.
31. Dentener MA, Greve JW, Maessen JG, Buurman WA: Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol. 1989;11:321-334.
32. Bemelmans MH, Gouma DJ, Buurman WA: LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J Immunol. 1993;151:5554-5562.
33. Fournier T, Bouach N, Delafosse C, Crestani B, Aubier M: Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli. J Immunol. 1999;163:2883-2890.
34. Sharma RJ, Macallan DC, Sedgwick P, Remick DG, Griffin GE: Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-alpha monoclonal antibody. Am J Physiol. 1992;262:R786-R793.
35. Klein RD, Su GL, Aminlari A, Alarcon WH, Wang SC: Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury. J Surg Res. 1998;78:42-47.
36. Venembre P, Boutten A, Seta N, Dehoux MS, Crestani B, Aubier M, Durand G: Secretion of alpha 1-antitrypsin by alveolar epithelial cells. FEBS Lett. 1994;346:171-174.
37. Dong Q, Wright JR: Expression of C-reactive protein by alveolar macrophages. J Immunol. 1996;156:4815-4820.
38. Mornex JF, Chytil-Weir A, Martinet Y, Courtney M, LeCocq JP, Crystal RG: Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest. 1986;77:1952-1961.
39. Sorensson J, Matejka GL, Ohlson M, Haraldsson B: Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol. 1999;276:H530-H534.
40. Horadagoda NU, Eckersall PD, Andrew L, Gallay P, Heumann D, Gibbs HA: Characterisation of bovine lipopolysaccharide binding protein and the in vivo acute phase response to Pasteurella haemolytica type A. Vet Immunol Immunopathol. 1995;49:61-74.
41. Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR: LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest. 1998;101:2065-2071.
42. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis. 1989;159:189-194.
43. Lengacher S, Jongeneel CV, Le Roy D, Lee JD, Kravchenko V, Ulevitch RJ, Glauser MP, Heumann D: Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. J Inflamm. 1995;47:165-172.
44. Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F, Schutt C: Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J Immunol. 1996;157:4119-4125.
45. Vreugdenhil AC, Snoek AM, van 't Veer C, Greve JW, Buurman WA: LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest. 2001;107:225-234.
46. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD: Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med. 1994;180:1025-1035.
47. Boutten A, Dehoux M, Deschenes M, Rouzeau JD, Bories PN, Durand G: Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol. 1992;22:2687-2695.
48. Laine E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP, Raichvarg D: Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation. 1990;14:1-9.
49. Bories PN, Feger J, Benbernou N, Rouzeau JD, Agneray J, Durand G: Prevalence of tri- and tetra-antennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation. 1990;14:315-323.
50. Jie Z, Cai Y, Yang W, Jin M, Zhu W, Zhu C: Protective effects of alpha 1-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin Med J (Engl). 2003;116:1678-1682.
51. De Haas CJ: New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein. FEMS Immunol Med Microbiol. 1999;26:197-202.
52. De Haas CJ, van der Zee R, Benaissa-Trouw B, van Kessel KP, Verhoef J, van Strijp JA Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. Infect Immun. 1999;67:2790-2796.